Dosimetric impact of bladder filling on organs at risk with barium contrast in the small bowel for adjuvant vaginal cuff brachytherapy
No Thumbnail Available
Identifiers
Date
2021-01-01
Authors
Salas Buzon, Maria del Carmen
Gutierrez Bayard, Lucia
Rodriguez Sanchez, Raquel
Quinones Rodriguez, Luis Angel
Sayago Gil, Sarah
Munoz Higueras, Cristina
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Termedia publishing house ltd
Abstract
Purpose: The aim of this prospective study was to analyze dosimetric impact of modifying bladder filling on dose distribution in organs at risk (OARs) when using contrast in the small bowel of patients under adjuvant therapy with high-dose-rate vaginal cuff brachytherapy (HDR-VCB) for endometrial cancer.Material and methods: This research included 19 patients who underwent laparoscopic surgery. They were treated with HDR-VCB and 2.5-3.5 cm diameter cylinders. Two successive computerized tomography (CT) scans were performed, with empty bladder and with bladder filled with 180 cc of saline solution. Bladder, rectum, sigmoid, and small bowel were delineated as OARs. Oral barium contrast was used to clearly visualize small bowel loops. Prescription dose was 7 Gy. Dose-volume histograms were generated for each OAR, with full and empty bladder to compare doses received.Results: Bladder distension had no dosimetric impact on the bladder, rectum, or sigmoid, unlike the small bowel. With full bladder, mean minimum dose at 2 cc (D-2cc) was not significantly higher for full vs. empty bladder (5.56 vs. 5.06 Gy, p = 0.07), whereas there was a significant reduction in the small bowel (1.68 vs. 2.70 Gy, p
Description
MeSH Terms
DeCS Terms
CIE Terms
Keywords
endometrial cancer, vaginal cuff brachytherapy, small bowel, bladder distention, barium, High-dose-rate, American brachytherapy, Endometrial cancer, 3-dimensional dosimetry, Vault brachytherapy, Guidelines, Carcinoma